Ultrasonic medical device maker receives declination letter from the DOJ

Misonix, Inc. reported in an August 16, 2019 filing with the Securities and Exchange Commission that it had received a declination letter from the US Department of Justice regarding the DOJ’s investigation of potential Foreign Corrupt Practices Act violations.  Misonix had previously disclosed that the DOJ and the SEC were investigating Misonix’s use of a third-party distributor in China.  Misonix said that in 2016 it had voluntarily self-disclosed to the DOJ and the SEC the findings from Misonix’s investigation of this third-party.  Misonix previously disclosed that in June 2019 the SEC informed Misonix that it had declined to take any enforcement action with respect to this matter.

Form 8-K

You are currently offline.